Skip to main content
Log in

Percutaneous septal ablation after unsuccessful surgical myectomy for patients with hypertrophic obstructive cardiomyopathy

  • ORIGINAL PAPER
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Objective

To evaluate the long-term outcome of percutaneous septal ablation (PTSMA) after a previous myectomy.

Background

Myectomy usually results in symptomatic improvement and reduction of dynamic obstruction in hypertrophic obstructive cardiomyopathy patients (HOCM-pts.). However, a few pts. remain with severe symptoms and obstruction, and need additional interventions.

Methods

We reviewed our database of 450 pts. who underwent PTSMA in our institution, and identified 11 (7 women, 4 men, mean age: 50 ± 14 years) with residual or recurrent NYHA class symptoms ≥III and significant left ventricular outflow obstruction (LVOTO) despite a previous myectomy 4 ± 5 years ago. In-hospital and follow-up data covering 6 ± 4 years, focusing on mortality and morbidity, symptoms, exercise capacity, and echocardiographic measures were collected.

Results

PTSMA was performed by injection of 3.6 ± 2.9 ml of alcohol. There was no peri-procedural or late death in this cohort. CK peaked at 614 ± 434 U/l. In addition to two pts. who already had a pacemaker implanted, two more (18%) who both had pre-existing left bundle branch block were pacemaker-dependent after PTSMA. During follow-up, 9 pts. (81%) reported significant and stable improvement. Two pts. (18%) developed progressive class III symptoms until their last follow-up, one of these together with persistent AF and a non-fatal stroke, the other received an ICD for primary prophylaxis and entered our pre-transplant program. Echo-Doppler showed sustained LVOTO elimination without global LV dilatation in all cases.

Conclusions

PTSMA is an effective non-surgical option for treating symptoms and residual or recurrent LVOTO after a previous surgical myectomy. The high rate of conduction disturbances in this post-surgical cohort translated into a higher rate of pacemaker dependency after PTSMA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Faber L, Meissner A, Ziemssen P, Seggewiss H (2000) Percutaneous transluminal septal myocardial ablation for HOCM: long-term follow-up in the first series of 25 patients. Heart 83:326–331

    Article  PubMed  CAS  Google Scholar 

  2. Faber L, Seggewiss H, Gietzen FH, Kuhn H, Boekstegers P, Neuhaus L, Seipel L, Horstkotte D (2005) Follow-up results of the “TASH”-registry of the German Cardiac Society. Z Kardiol 94:516–523

    Article  PubMed  CAS  Google Scholar 

  3. Faber L, Seggewiss H, Gleichmann U (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intra-procedural myocardial contrast echocardiography. Circulation 98:2415–2421

    PubMed  CAS  Google Scholar 

  4. Faber L, Seggewiss H, Ziemssen P (2000) Targeting percutaneous transluminal septal ablation for HOCM by intra-procedural echocardiographic monitoring. J Am Soc Echocardiogr 13:1074–1079

    Article  PubMed  CAS  Google Scholar 

  5. Faber L, Welge D, Fassbender D, Schmidt HK, Horstkotte D, Seggewiss H (2007) Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomopathy: managing the risk of procedure-related AV conduction. Disturbances. Int J Cardiol 119:163–167

    Article  PubMed  Google Scholar 

  6. Fernandes VL, Nagueh SF, Wang R, Roberts R, Spencer WH (2005) A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: the Baylor experience (1996–2002). Clin Cardiol 28:124–130

    Article  PubMed  Google Scholar 

  7. Joyal D, Arab D, Chen-Johnston C, Leya F (2007) Alcohol septal ablation after failed surgical myectomy. Catheter Cardiovasc Interv 69:999–1002

    Article  PubMed  Google Scholar 

  8. Kuhn H, Gietzen F, Leuner C, Gerenkamp T (1997) Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Eur Heart J 18:846–851

    PubMed  CAS  Google Scholar 

  9. Lakkis NM, Nagueh SF; Kleiman NS, Killip DM, He ZX, Verani M, Roberts R, Spencer WH III (1998) Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 98:1750–1755

    PubMed  CAS  Google Scholar 

  10. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED, Vogel RA, Abrams J, Bates ER, Brodie BR, Danias PG, Gregoratos G, Hlatky MA, Hochman JS, Kaul S, Lichtenberg RC, Lindner JR, O’Rourke RA, Pohost GM, Schofield RS, Tracy CM, Winters WL Jr, Klein WW, Priori SG, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Deckers J, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy (2003) A report of the American College of Cardiology foundation task force on clinical expert consensus documents and the European Society of Cardiology Committee for practice guidelines. J Am Coll Cardiol 42:1687–713

    Article  PubMed  Google Scholar 

  11. Minakata K, Dearani JA, Schaff HV, O’Leary PW, Ommen SR, Danielson GK (2005) Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg 80:851–856

    Article  PubMed  Google Scholar 

  12. Minami K, Boethig D, Woltersdorf H, Seifert D, Koerfer R (2002) Long term follow-up of surgical treatment of hypertrophic obstructive cardiomyopathy (HOCM): the role of concomitant cardiac procedures. Eur J Cardiothorac Surg 22:206–210

    Article  PubMed  Google Scholar 

  13. Nagueh SF, Buergler JM, Quinones MA, Spencer WH III, Lawrie GM (2007) Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 50:795–798

    Article  PubMed  Google Scholar 

  14. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, Schaff HV, Danielson GK, Tajik AJ, Nishimura RA (2005) Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 46:470–476

    Article  PubMed  Google Scholar 

  15. Robbins RC, Stinson EB, Daily PO (1996) Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 111:586–594

    Article  PubMed  CAS  Google Scholar 

  16. Schulte HD, Bircks W, Lösse B (1987) Techniques and complications of transaortic subvalvular myectomy in patients with hypertrophic obstructive cardiomyopathy (HOCM). Z Kardiol 76(Suppl 3):145–151

    PubMed  Google Scholar 

  17. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-months follow-up in 25 patients. J Am Coll Cardiol 31:252–258

    Article  PubMed  CAS  Google Scholar 

  18. Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211–214

    Article  PubMed  CAS  Google Scholar 

  19. Talreja DR, Nishimura RA, Edwards WD, Valeti US, Ommen SR, Tajik AJ, Dearani JA, Schaff HV, Holmes DR Jr (2004) Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol 44:2329–2332

    Article  PubMed  Google Scholar 

  20. Valettas N, Rho R, Beshai J, Lloyd CT, Ross HM, Kocovic D, Herrmann HC (2003) Alcohol septal ablation complicated by complete heart block and permanent pacemaker failure. Catheter Cardiovasc Interv 58:189–193

    Article  PubMed  Google Scholar 

  21. Woo A, Williams WG, Choi R, Wigle ED, Rozenblyum E, Fedwick K, Siu S, Ralph-Edwards A, Rakowski H (2005) Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 111:2033–2041

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lothar Faber MD, FESC, FACC.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faber, L., Welge, D., Hering, D. et al. Percutaneous septal ablation after unsuccessful surgical myectomy for patients with hypertrophic obstructive cardiomyopathy. Clin Res Cardiol 97, 899–904 (2008). https://doi.org/10.1007/s00392-008-0707-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-008-0707-0

Keywords

Navigation